Lilly to Participate in Cowen's 43rd Annual Health Care Conference

Rhea-AI Summary

Eli Lilly and Company (NYSE: LLY) will attend Cowen's 43rd Annual Health Care Conference on March 6, 2023. Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will engage in a fireside chat at 1:30 p.m. Eastern time. Interested investors and stakeholders can access the live audio webcast on Lilly's Investor website, with a replay available for 90 days thereafter. Lilly has been at the forefront of medical innovation for nearly 150 years, helping over 47 million people worldwide by advancing diabetes care, combating obesity, and tackling severe health challenges like Alzheimer's disease and difficult cancers.

News Market Reaction – LLY

-0.27%

-0.27% Session move

In the trading session that priced this news, LLY declined 0.27%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

INDIANAPOLIS, Feb. 21, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Cowen's 43rd Annual Health Care Conference on Monday, March 6, 2023. Mike Mason, executive vice president and president, Lilly Diabetes and Obesity, will participate in a fireside chat at 1:30 p.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram and LinkedIn. F-LLY

Refer to:	Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
	Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors)

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-cowens-43rd-annual-health-care-conference-301751130.html

SOURCE Eli Lilly and Company

FAQ

When will Eli Lilly participate in Cowen's Health Care Conference?

Eli Lilly will participate in Cowen's 43rd Annual Health Care Conference on March 6, 2023.

Who will represent Eli Lilly at the Cowen Health Care Conference?

Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will represent Eli Lilly.

What time is Eli Lilly's presentation at the Cowen Health Care Conference?

Eli Lilly's presentation will take place at 1:30 p.m. Eastern time.

How can I listen to Eli Lilly's presentation at the conference?

The presentation can be accessed via a live audio webcast on Lilly's Investor website.

Will there be a replay of Eli Lilly's conference presentation?

Yes, a replay of the presentation will be available for approximately 90 days on Lilly's Investor website.